{
    "clinical_study": {
        "@rank": "51975", 
        "arm_group": [
            {
                "arm_group_label": "High protein diet", 
                "arm_group_type": "Experimental", 
                "description": "High protein diet during caloric restriction"
            }, 
            {
                "arm_group_label": "Standard protein diet", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Standard protein diet during caloric restriction"
            }
        ], 
        "brief_summary": {
            "textblock": "The present study is designed to investigate whether a high protein diet will preserve\n      muscle mass during caloric restriction in older adults."
        }, 
        "brief_title": "Protect - The Impact of a High Protein Diet on Preservation of Muscle Mass", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Overweight and obese subjects (BMI 27-40 kg/m2)\n\n          -  Waist circumference male:\u2265 102 cm, female: \u2265 88 cm\n\n          -  Willingness and ability to comply with the protocol\n\n        Exclusion Criteria:\n\n          -  Renal insufficiency\n\n          -  Co-morbidities\n\n          -  Type 1 & 2 diabetics (Fasting glucose level \u2265 7 mmol/L)\n\n          -  Cancer\n\n          -  COPD\n\n          -  Participation in weight loss program 3 months before the intervention\n\n          -  Participation of any heavy resistance-type exercise training (>1 wk) the last 2 y.\n\n          -  Intentional or unintentional weight loss (> 3 kg in the last 3 months)\n\n          -  Severe loss appetite\n\n          -  Diagnosed allergy to milk products\n\n          -  Gastric bypass\n\n          -  Supplements or medication use for weight loss\n\n          -  Participation in any other intervention trial\n\n          -  Women can only participate if they are postmenopausal (last period \u2265 a year ago)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "61", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01915030", 
            "org_study_id": "WM002-wp3"
        }, 
        "intervention": [
            {
                "arm_group_label": "High protein diet", 
                "description": "controlled feeding trail. Both arms are caloric restricted", 
                "intervention_name": "High protein diet", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Standard protein diet", 
                "intervention_name": "standard protein diet", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Muscle", 
            "Physical performance", 
            "Protein", 
            "Diet", 
            "Caloric restriction"
        ], 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wageningen", 
                    "country": "Netherlands", 
                    "state": "Gelderland", 
                    "zip": "6703HD"
                }, 
                "name": "Wageningen University"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "Protect The Impact of a High Protein Diet on the Preservation of Muscle Mass During Caloric Restriction in Middle Age and Elderly People", 
        "overall_official": {
            "affiliation": "Prof. Wageningen University", 
            "last_name": "Lisette de Groot, professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Netherlands: Medical Ethics Review Committee (METC)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "DEXA scan", 
            "measure": "Change in Body composition", 
            "safety_issue": "No", 
            "time_frame": "baseline and 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01915030"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Short Physical Performance Battery (SPPB), maximum score is 12.\nLeg strength by 1 Repetition Maximum, both leg extension and leg press\nHandgrip strength\nTime to walk 400m", 
                "measure": "Physical performance", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 weeks"
            }, 
            {
                "description": "Glucose, insulin, HbA1c, lipid profile", 
                "measure": "Blood related parameters", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 weeks"
            }, 
            {
                "description": "muscle biopsies (muscle fiber type)", 
                "measure": "Muscle related parameters", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 weeks"
            }, 
            {
                "description": "Questionnaire LAPAQ - Activities of Daily Living", 
                "measure": "Physical activity", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 weeks"
            }
        ], 
        "source": "Wageningen University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Maastricht University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Top Institute Food and Nutrition", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Wageningen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}